HB2943, titled the Gabriel Rosenberg Dyspraxia/DCD Coverage Act, would require the Comptroller General of the United States to study how insurance coverage is currently provided for dyspraxia, also referred to as developmental coordination disorder (DCD). The bill does not itself mandate new coverage; instead, it directs the Government Accountability Office to examine coverage across Medicare, Medicaid, other federal health care programs, employer-sponsored group health plans, and individual and group health insurance coverage.
The required report would assess whether coverage exists, what services are typically covered, whether age-based limits affect access, and what barriers prevent coverage, including provider shortages. It also asks for an evaluation of whether health plans comply with federal mental health and substance use parity-related requirements, whether children lose coverage as they age into adulthood because of diagnostic criteria, and whether CMS should issue guidance to improve coverage under Medicare and Medicaid. The study is intended to produce recommendations for Congress and for insurers on improving access to treatment-related services for people with dyspraxia/DCD.
Impact
If enacted, the bill would not directly change benefit mandates or reimbursement rules, but it would create a federal report that could inform future legislation, agency guidance, or insurance policy changes. It would affect federal oversight of Medicare, Medicaid, FEHBP, and private health coverage by requiring a comprehensive review of how dyspraxia/DCD-related services are covered and where gaps exist. The bill could also draw attention to state Medicaid practices and to coverage limitations in private insurance plans, especially for children transitioning to adulthood.
Sentiment
Based on the bill text and its introduction as a named coverage study, the overall sentiment appears supportive and informational rather than adversarial. The bill is framed as a bipartisan effort, introduced by Representatives Lawler and Gottheimer, and there is no recorded committee debate or vote history in the provided materials. The tone suggests a shared interest in improving understanding of a relatively under-recognized developmental disorder and identifying coverage barriers.
Contention
The main points of potential contention are not explicit in the available record, but the bill’s focus on insurance coverage could raise questions about whether findings might lead to new coverage expectations or administrative burdens for public and private payers. Another possible issue is the bill’s attention to age cutoffs and adult diagnostic criteria, which may highlight disagreements over when treatment should be covered and by whom. The study’s recommendation that CMS consider guidance for Medicare and Medicaid could also be debated by stakeholders concerned about federal involvement in coverage decisions.
Expressing support for the designation of October 9 through October 16, 2025, as "National Dyspraxia/Developmental Coordination Disorder (DCD) Awareness Week" and a commitment to raise awareness of dyspraxia/DCD in the United States.